Article

Tenascin-C potentiates Wnt signaling in thyroid cancer

medRxiv · 2024 · Hartmann, H. A.; Loberg, M. A.; Xu, G. J.; Schwarzkopf, A. C.; Chen, S.-C.; Phifer, C. J.; Caroland, K.; Chen, H.-C.; Diaz, D.; Tigue, M. L.; Hesterberg, A. B.; Gallant, J.-N.; Shaddy, S. M.; Sheng, Q.; Netterville, J. L.; Rohde, S. L.; Solorzano, C. C.; Bischoff, L. A.; Baregamian, N.; Hurley, P. J.; Murphy, B. A.; Choe, J. H.; Huang, E. C.; Ye, F.; Lee, E.; Weiss, V. L.

Key facts

Title Tenascin-C potentiates Wnt signaling in thyroid cancer
First author Hartmann, H. A.; Loberg, M. A.; Xu, G. J.; Schwarzkopf, A. C.; Chen, S.-C.; Phifer, C. J.; Caroland, K.; Chen, H.-C.; Diaz, D.; Tigue, M. L.; Hesterberg, A. B.; Gallant, J.-N.; Shaddy, S. M.; Sheng, Q.; Netterville, J. L.; Rohde, S. L.; Solorzano, C. C.; Bischoff, L. A.; Baregamian, N.; Hurley, P. J.; Murphy, B. A.; Choe, J. H.; Huang, E. C.; Ye, F.; Lee, E.; Weiss, V. L.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.11.04.621959
Devices mentioned K042152, K850512, K850513, K852288, K852441, K852475, K852485, K854177, K854178, K854179, K854180, K854181 and 10 more
Product codes mentioned CDT, CEO, CFN, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DFZ and 5 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature